Comparative Effectiveness of Dalerpen vs. Branded and Other Generic Tadalafil: The “Shift Study”

<b>Background:</b> Phosphodiesterase type 5 inhibitors (PDE5i), particularly tadalafil and sildenafil, are the first-line therapies for erectile dysfunction (ED). After the patent expiration of branded tadalafil in 2017, generic formulations became available. Despite equivalent efficacy,...

Full description

Bibliographic Details
Published in:Uro
Main Authors: Davide Arcaniolo, Carlos Miacola, Marco Bitelli, Luca Boeri, Tommaso Cai, Carlo Ceruti, Celeste Manfredi, Ilaria Ortensi, Fabrizio Palumbo, Giorgio Piubello, Chiara Polito, Nicolò Schifano, Alessandro Palmieri
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Subjects:
Online Access:https://www.mdpi.com/2673-4397/5/3/14

Similar Items